Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 138 articles:
HTML format
Text format



Single Articles


    January 2019

  1. Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool.
    Gastroenterology. 2019 Jan 23. pii: S0016-5085(19)30099.
    PubMed     Text format    


  2. CROSS R, Ko CW, Singh S
    Mild-to-Moderate Ulcerative Colitis Guideline.
    Gastroenterology. 2019 Jan 23. pii: S0016-5085(19)30097.
    PubMed     Text format    



  3. Management of Mild-to-Moderate Ulcerative Colitis: Patient Guide.
    Gastroenterology. 2019 Jan 19. pii: S0016-5085(19)30096.
    PubMed     Text format    


  4. MAHADEVAN U, Robinson C, Bernasko N, Boland B, et al
    Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway - A Report from the American Gastroenterological Association IBD Parenthood Project Working Group.
    Gastroenterology. 2019 Jan 16. pii: S0016-5085(18)35437.
    PubMed     Text format    


  5. YE L, Jiang Z, Cao Q
    Massive bleeding and perforation with endoscopic multiple deep ulcers in a patient with ulcerative colitis after colectomy.
    Gastroenterology. 2019 Jan 10. pii: S0016-5085(19)30029.
    PubMed     Text format    


  6. DE BOER NKH
    Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones.
    Gastroenterology. 2019;156:11-14.
    PubMed     Text format    


  7. LEHLE AS, Farin HF, Marquardt B, Michels BE, et al
    Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency.
    Gastroenterology. 2019;156:275-278.
    PubMed     Text format    


  8. BORGERINK MMH, Weersma RK, Visschedijk MC
    A Case Report of a Young Adult With Progressive Bloody Diarrhea, Protein-Losing Enteropathy, and Extended Polyposis Coli.
    Gastroenterology. 2019;156:e10-e11.
    PubMed     Text format    


  9. HANAUER SB, Sandborn WJ, Lichtenstein GR
    Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
    Gastroenterology. 2019;156:36-42.
    PubMed     Text format     Abstract available


    December 2018
  10. KO CW, Singh S, Feuerstein JD, Falck-Ytter C, et al
    American Gastroenterological Association Institute Guideline on the Management of Mild-Moderate Ulcerative Colitis.
    Gastroenterology. 2018 Dec 18. pii: S0016-5085(18)35407.
    PubMed     Text format    


  11. SINGH S, Feuerstein JD, Binion DG, Tremaine WJ, et al
    American Gastroenterological Association Technical Review on the Management of Mild to Moderate Ulcerative Colitis.
    Gastroenterology. 2018 Dec 18. pii: S0016-5085(18)35406.
    PubMed     Text format     Abstract available


  12. PARAMSOTHY S, Nielsen S, Kamm MA, Deshpande NP, et al
    Specific Bacteria and Metabolites Associated with Response to Fecal Microbiota Transplantation in Patients with Ulcerative Colitis.
    Gastroenterology. 2018 Dec 6. pii: S0016-5085(18)35387.
    PubMed     Text format     Abstract available


  13. PHILIPOSE J, El Douaihy Y, Liliane DK
    An Unusual Case of Bloody Diarrhea in a Young Man.
    Gastroenterology. 2018;155:1695-1696.
    PubMed     Text format    


    November 2018
  14. SANDBORN WJ, Cyrille M, Hansen MB, Feagan BG, et al
    Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35283.
    PubMed     Text format     Abstract available


  15. BIANCHERI P, Watson AJM
    High Mucosal Plasma Cell Numbers and Low Serum TREM-1 Levels May Predict Nonresponsiveness to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35291.
    PubMed     Text format    


  16. LIU G, Jin S, Jiang Q
    Interleukin 6 receptor and inflammatory bowel disease: a Mendelian randomization study.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35266.
    PubMed     Text format    


  17. ARGYRIOU K, Khan M, Samuel S
    Multiple Unusual Ulcerated Skin Lesions in a Crohn's Disease Patient.
    Gastroenterology. 2018;155:e17-e18.
    PubMed     Text format    


    October 2018
  18. GODEFROY E, Alameddine J, Montassier E, Mathe J, et al
    Expression of CCR6 and CXCR6 by Gut-Derived CD4(+)/CD8alpha(+) T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:1205-1217.
    PubMed     Text format     Abstract available


  19. SHAH SC, Khalili H, Gower-Rousseau C, Olen O, et al
    Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries.
    Gastroenterology. 2018;155:1079-1089.
    PubMed     Text format     Abstract available


  20. RUTGEERTS P, Gasink C, Chan D, Lang Y, et al
    Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:1045-1058.
    PubMed     Text format     Abstract available


  21. GOLD SL, Magro C, Scherl E
    A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease.
    Gastroenterology. 2018;155:981-982.
    PubMed     Text format    


    September 2018
  22. KELLY CP, Wilcox MH, Glerup H, Aboo N, et al
    Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease.
    Gastroenterology. 2018 Sep 15. pii: S0016-5085(18)34757.
    PubMed     Text format    


  23. SORRENTINO DR
    Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across?
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34773.
    PubMed     Text format    


  24. DULAI PS
    Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34940.
    PubMed     Text format    


  25. KANEIDER NC, Kaser A
    Personalized Treatment in Inflammatory Bowel Disease: For Another Time.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34937.
    PubMed     Text format    


  26. DULAI PS, Boland BS, Singh S, Chaudrey K, et al
    Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:687-695.
    PubMed     Text format     Abstract available


  27. MATRO R, Martin CF, Wolf D, Shah SA, et al
    Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Gastroenterology. 2018;155:696-704.
    PubMed     Text format     Abstract available


  28. CLERC F, Novokmet M, Dotz V, Reiding KR, et al
    Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:829-843.
    PubMed     Text format     Abstract available


  29. VANDUSSEN KL, Stojmirovic A, Li K, Liu TC, et al
    Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease.
    Gastroenterology. 2018;155:815-828.
    PubMed     Text format     Abstract available


  30. CHEBLI JMF, de Oliveira Moreira B, da Rocha Ribeiro TC
    An Unusual Cause of Skin Rash in Crohn's Disease.
    Gastroenterology. 2018;155:618-620.
    PubMed     Text format    


    August 2018
  31. SHAH SC, Faith J, Colombel JF
    Microbial-host interactions in inflammatory bowel disease, functional bowel disease, obesity and obesity-related metabolic disease.
    Gastroenterology. 2018 Aug 31. pii: S0016-5085(18)34765.
    PubMed     Text format    


  32. KOUNTOURAS J, Polyzos SA, Deretzi G
    Multiple Bi-directionality Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34877.
    PubMed     Text format    


  33. WEERSMA RK, Xavier RJ, Vermeire S, Barrett JC, et al
    "Multi-omics analyses to deliver the most effective treatment to every patient with inflammatory bowel disease".
    Gastroenterology. 2018 Aug 2. pii: S0016-5085(18)34827.
    PubMed     Text format    


  34. LE L, Fung BM, Tabibian JH
    Capsule Endoscopy for Refractory Iron Deficiency Anemia in Crohn's Disease: Captivating Pathology, Hybrid Therapy.
    Gastroenterology. 2018;155:276-277.
    PubMed     Text format    


  35. KIRCHGESNER J, Lemaitre M, Carrat F, Zureik M, et al
    Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:337-346.
    PubMed     Text format     Abstract available


    July 2018
  36. NISHIO M, Hirooka K, Doi Y
    Pulmonary Arterial Hypertension Associated With the Chinese Herb Indigo Naturalis for Ulcerative Colitis: It May Be Reversible.
    Gastroenterology. 2018 Jul 9. pii: S0016-5085(18)34649.
    PubMed     Text format    


  37. TELESCO SE, Brodmerkel C, Zhang H, Kim LL, et al
    Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-label Trial of Patients With Ulcerative Colitis.
    Gastroenterology. 2018 Jul 4. pii: S0016-5085(18)34719.
    PubMed     Text format     Abstract available


  38. LIU B, Dong K, Dong R
    The Diagnosis Effect of DNA Methylation in Inflammatory Bowel Diseases.
    Gastroenterology. 2018;155:229.
    PubMed     Text format    


  39. GENG H, Bu HF, Liu F, Wu L, et al
    In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration.
    Gastroenterology. 2018;155:144-155.
    PubMed     Text format     Abstract available


  40. DANESE S, Bonovas S, Lopez A, Fiorino G, et al
    Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
    Gastroenterology. 2018;155:76-87.
    PubMed     Text format     Abstract available


  41. DHILLON AS, Johnston EL, Sanderson JD
    A Case of Unusual Ileal Discoloration.
    Gastroenterology. 2018;155:e1-e2.
    PubMed     Text format    


    June 2018
  42. LYNN AM, Loftus EV Jr
    Illuminating the Black Box: The Real Risk of Serious Infection with Inflammatory Bowel Disease Therapies.
    Gastroenterology. 2018 Jun 29. pii: S0016-5085(18)34695.
    PubMed     Text format    


  43. HERFARTH H, Barnes EL, Valentine JF, Hanson J, et al
    Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis.
    Gastroenterology. 2018 Jun 29. pii: S0016-5085(18)34688.
    PubMed     Text format     Abstract available


  44. QUARANTA M, Wilson R, Serra EG, Pandey S, et al
    Genomics Identifies XIAP Deficiency in an Adult Patient With Inflammatory Bowel Disease: The Clinical and Health Care Impact.
    Gastroenterology. 2018 Jun 9. pii: S0016-5085(18)34529.
    PubMed     Text format    


  45. NUNES G, Patita M, Roque Ramos L
    An Uncommon Clinical Sign in a Patient with Ulcerative Colitis.
    Gastroenterology. 2018 Jun 5. pii: S0016-5085(18)34608.
    PubMed     Text format    


  46. AMININEJAD L, Charloteaux B, Theatre E, Liefferinckx C, et al
    Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:2165-2177.
    PubMed     Text format     Abstract available


  47. DENSON LA, Jurickova I, Karns R, Shaw KA, et al
    Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease.
    Gastroenterology. 2018;154:2097-2110.
    PubMed     Text format     Abstract available


  48. KHOURY T, Israeli E, Yaari S
    Unfolding the Diagnosis: Rare Endoscopic Features of Unusual Cause of Colitis.
    Gastroenterology. 2018;154:e7-e8.
    PubMed     Text format    


    May 2018
  49. PARISINOS CA, Serghiou S, Katsoulis M, George MJ, et al
    Variation in Interleukin 6 Receptor Gene Associates with Risk of Crohn's Disease and Ulcerative Colitis.
    Gastroenterology. 2018 May 15. pii: S0016-5085(18)34542.
    PubMed     Text format     Abstract available


  50. UHLIG HH, Booth C
    Inflammatory Bowel Disease and Immune Defects: A Spectrum of Genetic Variants and Clinical Pathogenicity.
    Gastroenterology. 2018 May 5. pii: S0016-5085(18)34485.
    PubMed     Text format    


  51. ADEDOKUN OJ, Xu Z, Gasink C, Jacobstein D, et al
    Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:1660-1671.
    PubMed     Text format     Abstract available


  52. GRACIE DJ, Guthrie EA, Hamlin PJ, Ford AC, et al
    Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2018;154:1635-1646.
    PubMed     Text format     Abstract available


  53. YANG LS, Dowling D
    A Rare Complication of Infliximab.
    Gastroenterology. 2018;154:e5-e6.
    PubMed     Text format    


  54. DEBOURDEAU A, Bozon A, Altwegg R
    An Uncommon Cause of Feverish Swelling in a Patient With Crohn's Disease.
    Gastroenterology. 2018;154:1584-1585.
    PubMed     Text format    


    April 2018
  55. MAHAKKANUKRAUH P, Sinthubua A, Das S
    Methylated MicroRNA Biomarkers for Identifying Ulcerative Colitis-Associated Colorectal Cancers.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30311.
    PubMed     Text format    


  56. BOSCH S, de Meij TGJ, de Boer NK
    Altered Tryptophan Levels in Patients With Inflammatory Bowel Disease Owing to Colonic Leakage, Metabolism, or Malabsorption?
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30308.
    PubMed     Text format    


  57. CHARPENTIER C, Kottler D, Fite C, Pelletier AL, et al
    A Surprising Granulomatous Cheilitis.
    Gastroenterology. 2018;154:1239-1240.
    PubMed     Text format    


  58. D'HAENS G, Vermeire S, Lambrecht G, Baert F, et al
    Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
    Gastroenterology. 2018;154:1343-1351.
    PubMed     Text format     Abstract available


  59. SIMURINA M, de Haan N, Vuckovic F, Kennedy NA, et al
    Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.
    Gastroenterology. 2018;154:1320-1333.
    PubMed     Text format     Abstract available


  60. PANES J, Garcia-Olmo D, Van Assche G, Colombel JF, et al
    Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2018;154:1334-1342.
    PubMed     Text format     Abstract available


  61. ROY S, Esmaeilniakooshkghazi A, Patnaik S, Wang Y, et al
    Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation.
    Gastroenterology. 2018;154:1405-1420.
    PubMed     Text format     Abstract available


    March 2018
  62. MAHADEVAN U, Silverberg MS
    Inflammatory Bowel Disease.
    Gastroenterology. 2018 Mar 14. pii: S0016-5085(18)30008.
    PubMed     Text format    


  63. BRUINING DH, Zimmermann EM, Loftus EV Jr., Sandborn WJ, et al
    Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease.
    Gastroenterology. 2018;154:1172-1194.
    PubMed     Text format     Abstract available


    February 2018
  64. LEY D, Jones J, Parrish J, Salih S, et al
    Methotrexate Reduces DNA Integrity in Sperm From Men with Inflammatory Bowel Disease.
    Gastroenterology. 2018 Feb 23. pii: S0016-5085(18)30229.
    PubMed     Text format     Abstract available


  65. PAPAMICHAEL K, Osterman MT, Siegel CA, Melmed GY, et al
    Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
    Gastroenterology. 2018 Feb 9. pii: S0016-5085(18)30006.
    PubMed     Text format    


  66. YE BD
    Introducing Traditional Herbal Medicine into Conventional Health Care in Treating Ulcerative Colitis: Primum Non Nocere.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30160.
    PubMed     Text format    


  67. MENEES SB, Almario CV, Spiegel BMR, Chey WD, et al
    Prevalence of and Factors Associated with Fecal Incontinence-Results From a Population-based Survey.
    Gastroenterology. 2018 Feb 3. pii: S0016-5085(18)30144.
    PubMed     Text format     Abstract available


  68. EVERHOV AH, Halfvarson J, Myrelid P, Sachs MC, et al
    Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Gastroenterology. 2018;154:518-528.
    PubMed     Text format     Abstract available


  69. HOWELL KJ, Kraiczy J, Nayak KM, Gasparetto M, et al
    DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
    Gastroenterology. 2018;154:585-598.
    PubMed     Text format     Abstract available


    January 2018
  70. JABOLI F, Pouillon L, Bossuyt P, Danese S, et al
    Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30101.
    PubMed     Text format    


  71. FEAGAN BG, Sands BE, Rossiter G, Li X, et al
    Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease.
    Gastroenterology. 2018;154:61-64.
    PubMed     Text format     Abstract available


    December 2017
  72. LIU L, Nishihara R, Qian ZR, Tabung FK, et al
    Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.
    Gastroenterology. 2017;153:1517-1530.
    PubMed     Text format     Abstract available


  73. NIKOLAUS S, Schulte B, Al-Massad N, Thieme F, et al
    Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Gastroenterology. 2017;153:1504-1516.
    PubMed     Text format     Abstract available


    November 2017
  74. DAI C, Jiang M, Sun MJ
    Clostridium difficile Infection among Individuals With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Nov 23. pii: S0016-5085(17)36334.
    PubMed     Text format    


  75. NAGANUMA M, Sugimoto S, Mitsuyama K, Kobayashi T, et al
    Efficacy of Indigo naturalis in a Multicenter Randomized Controlled Trial of Patients with Ulcerative Colitis.
    Gastroenterology. 2017 Nov 22. pii: S0016-5085(17)36382.
    PubMed     Text format     Abstract available


  76. DULAI PS, Singh S, Ohno-Machado L, Sandborn WJ, et al
    Population Health Management for Inflammatory Bowel Disease.
    Gastroenterology. 2017 Nov 6. pii: S0016-5085(17)36337.
    PubMed     Text format     Abstract available


  77. KUMAR A, Chatterjee I, Gujral T, Alakkam A, et al
    Activation of Nuclear Factor-kappaB by Tumor Necrosis Factor in Intestinal Epithelial Cells and Mouse Intestinal Epithelia Reduces Expression of the Chloride Transporter SLC26A3.
    Gastroenterology. 2017;153:1338-1350.
    PubMed     Text format     Abstract available


  78. HEGAZY AN, West NR, Stubbington MJT, Wendt E, et al
    Circulating and Tissue-Resident CD4(+) T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation.
    Gastroenterology. 2017;153:1320-1337.
    PubMed     Text format     Abstract available


    October 2017
  79. GRACIE DJ, Ford AC
    A Bidirectional Relationship Between Symptom Reporting and Perceived Stress, But Not Disease Activity, in Inflammatory Bowel Disease: More Questions Than Answers?
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36194.
    PubMed     Text format    


  80. JULSGAARD M, Kjeldsen J, Bibby BM, Brock B, et al
    Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36132.
    PubMed     Text format    


    September 2017
  81. KESAR V, Swaminath A
    Hepatic masses in a patient in Inflammatory bowel disease.
    Gastroenterology. 2017 Sep 9. pii: S0016-5085(17)36140.
    PubMed     Text format    


  82. CHAPMAN S, El-Matary W
    Screening for Epstein-Barr Virus Status and Risk of Hemophagocytic Lymphohistiocytosis in Children With Inflammatory Bowel Disease on Azathioprine.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)36033.
    PubMed     Text format    


  83. BARNES EL, Herfarth HH
    The Usefulness of Serologic Testing for Epstein-Barr Virus Before Initiation of Therapy for Inflammatory Bowel Disease.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)36035.
    PubMed     Text format    


  84. VANDE CASTEELE N, Herfarth H, Katz J, Falck-Ytter Y, et al
    American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.
    Gastroenterology. 2017;153:835-857.
    PubMed     Text format     Abstract available


  85. WELLMAN AS, Metukuri MR, Kazgan N, Xu X, et al
    Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota.
    Gastroenterology. 2017;153:772-786.
    PubMed     Text format     Abstract available


    August 2017
  86. TOIYAMA Y, Okugawa Y, Tanaka K, Araki T, et al
    A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer.
    Gastroenterology. 2017 Aug 25. pii: S0016-5085(17)36070.
    PubMed     Text format     Abstract available


  87. TSAI JH, Rabinovitch PS, Huang D, Small T, et al
    Association of Aneuploidy and Flat Dysplasia With Development of High-Grade Dysplasia or Colorectal Cancer in Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Aug 23. pii: S0016-5085(17)36064.
    PubMed     Text format     Abstract available


  88. FEUERSTEIN JD, Nguyen GC, Kupfer SS, Falck-Ytter Y, et al
    Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35963.
    PubMed     Text format    



  89. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Clinical Decision Support Tool.
    Gastroenterology. 2017 Aug 1. pii: S0016-5085(17)35970.
    PubMed     Text format    


    July 2017

  90. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide.
    Gastroenterology. 2017 Jul 31. pii: S0016-5085(17)35968.
    PubMed     Text format    


  91. SURESH S, Govani SM, Waljee AK
    Ten Hove JR et al. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Endoscopy. 2017 Feb;49(2):161-168.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35957.
    PubMed     Text format    


  92. POUILLON L, Bossuyt P, Peyrin-Biroulet L
    Tofacitinib is the right OCTAVE for ulcerative colitis.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35958.
    PubMed     Text format    


  93. PARLATO M, Charbit-Henrion F, Hayes P, Tiberti A, et al
    First Identification of Biallelic Inherited DUOX2 Inactivating Mutations as a Cause of Very Early Onset Inflammatory Bowel Disease.
    Gastroenterology. 2017 Jul 3. pii: S0016-5085(17)35484.
    PubMed     Text format    


  94. GONSKY R, Fleshner P, Deem RL, Biener-Ramanujan E, et al
    Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
    Gastroenterology. 2017;153:219-232.
    PubMed     Text format     Abstract available


  95. DIETZ AB, Dozois EJ, Fletcher JG, Butler GW, et al
    Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2017;153:59-62.
    PubMed     Text format     Abstract available


  96. SANDS BE, Chen J, Feagan BG, Penney M, et al
    Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
    Gastroenterology. 2017;153:77-86.
    PubMed     Text format     Abstract available


    June 2017
  97. DANESE S, Fiorino G, Peyrin-Biroulet L
    Filgotinib in Crohn Disease: JAK Is Back.
    Gastroenterology. 2017 Jun 24. pii: S0016-5085(17)35825.
    PubMed     Text format    


  98. HOLVOET T, Devriese S, Castermans K, Boland S, et al
    Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35798.
    PubMed     Text format     Abstract available


  99. CHANG J, Leong RW, Wasinger V, Ip M, et al
    Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Gastroenterology. 2017 Jun 7. pii: S0016-5085(17)35731.
    PubMed     Text format     Abstract available


  100. KANIS SL, van der Woude CJ
    Endoscopy for Inflammatory Bowel Disease During Pregnancy: Only When There Is a Strong Indication.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35603.
    PubMed     Text format    


    May 2017
  101. GRACIE DJ, Ford AC
    Irritable bowel syndrome-type symptoms are associated with psychological co-morbidity, reduced quality of life, and healthcare utilization in patients with inflammatory bowel disease.
    Gastroenterology. 2017 May 29. pii: S0016-5085(17)35679.
    PubMed     Text format    


  102. YADAV P, Ellinghaus D, Remy G, Freitag-Wolf S, et al
    Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.
    Gastroenterology. 2017 May 12. pii: S0016-5085(17)35596.
    PubMed     Text format     Abstract available


  103. SINGH H, Nugent Z, Yu BN, Lix LM, et al
    Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35554.
    PubMed     Text format     Abstract available


  104. MISRA R, Arebi N
    Re: Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35405.
    PubMed     Text format    


  105. LEONG RW, Ooi M, Corte C, Yau Y, et al
    Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:1337-1344.
    PubMed     Text format     Abstract available


    April 2017
  106. MAHADEVAN U
    How To Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities.
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35540.
    PubMed     Text format    


    March 2017
  107. CHIRIAC MT, Buchen B, Wandersee A, Hundorfean G, et al
    Activation of Epithelial STAT1 by Interleukin 28 Controls Mucosal Healing in Mice with Colitis and is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Mar 22. pii: S0016-5085(17)30322.
    PubMed     Text format     Abstract available


  108. WEISMULLER TJ, Trivedi PJ, Bergquist A, Imam M, et al
    Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Gastroenterology. 2017 Mar 5. pii: S0016-5085(17)30236.
    PubMed     Text format     Abstract available


    February 2017
  109. HYAMS JS, Dubinsky MC, Baldassano RN, Colletti RB, et al
    Infliximab not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30148.
    PubMed     Text format     Abstract available


  110. ENNS RA, Hookey L, Armstrong D, Bernstein CN, et al
    Clinical Practice Guidelines for the Use of Video Capsule Endoscopy.
    Gastroenterology. 2017;152:497-514.
    PubMed     Text format     Abstract available


  111. HAWKEY CJ, Hommes DW
    Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?
    Gastroenterology. 2017;152:389-397.
    PubMed     Text format     Abstract available


  112. REGUEIRO M, Greer JB, Szigethy E
    Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:430-439.
    PubMed     Text format     Abstract available


  113. LEWIS JD, Abreu MT
    Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:398-414.
    PubMed     Text format     Abstract available


  114. ABRAHAM C, Dulai PS, Vermeire S, Sandborn WJ, et al
    Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:374-388.
    PubMed     Text format     Abstract available


  115. SARTOR RB, Wu GD
    Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
    Gastroenterology. 2017;152:327-339.
    PubMed     Text format     Abstract available


  116. MAHADEVAN U, McConnell RA, Chambers CD
    Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2017;152:451-462.
    PubMed     Text format     Abstract available


  117. VELAYOS F, Kathpalia P, Finlayson E
    Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary?
    Gastroenterology. 2017;152:440-450.
    PubMed     Text format     Abstract available


  118. PANES J, Jairath V, Levesque BG
    Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:362-373.
    PubMed     Text format     Abstract available


  119. CHEIFETZ AS, Gianotti R, Luber R, Gibson PR, et al
    Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:415-429.
    PubMed     Text format     Abstract available


  120. STAPPENBECK TS, McGovern DP
    Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease.
    Gastroenterology. 2017;152:322-326.
    PubMed     Text format     Abstract available


  121. COLOMBEL JF, Narula N, Peyrin-Biroulet L
    Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:351-361.
    PubMed     Text format     Abstract available


  122. RIEDER F, Fiocchi C, Rogler G
    Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:340-350.
    PubMed     Text format     Abstract available


    January 2017
  123. ROSEN MJ, Karns R, Vallance JE, Bezold R, et al
    Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-only Crohn's Disease in Treatment-naive Pediatric Patients.
    Gastroenterology. 2017 Jan 26. pii: S0016-5085(17)30073.
    PubMed     Text format     Abstract available


  124. POPP V, Gerlach K, Mott S, Turowska A, et al
    Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
    Gastroenterology. 2017;152:176-192.
    PubMed     Text format     Abstract available


    December 2016
  125. VAZIRI H, Anderson JC
    Is Chromoendoscopy Superior to Standard Colonoscopy for Long-term Surveillance of Patients With Inflammatory Bowel Disease?
    Gastroenterology. 2016 Dec 28. pii: S0016-5085(16)35525.
    PubMed     Text format    


  126. COLOMBEL JF, Mahadevan U
    Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms.
    Gastroenterology. 2016 Dec 10. pii: S0016-5085(16)35464.
    PubMed     Text format    


    November 2016
  127. SHIRAISHI T, Shoji H, Akazawa Y
    Gingival Carcinoma in a Patient With Ulcerative Colitis?
    Gastroenterology. 2016 Nov 25. pii: S0016-5085(16)34955.
    PubMed     Text format    


  128. FRANKE A
    Inflammatory Bowel Disease: A Global Disease That Needs a Broader Ensemble of Populations.
    Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35395.
    PubMed     Text format    


  129. YANG Y, Owyang C, Wu GD
    East Meets West: The Increasing Incidence of Inflammatory Bowel Disease in Asia as a Paradigm for Environmental Effects on the Pathogenesis of Immune-Mediated Disease.
    Gastroenterology. 2016 Nov 1. pii: S0016-5085(16)35281.
    PubMed     Text format    


    October 2016
  130. EL-MATARY W
    Risk of Attenuated Live Vaccine-Induced Infection in Infants of Mothers Receiving Anti-Tumor Necrosis Factor Agents for Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 31. pii: S0016-5085(16)35187.
    PubMed     Text format    


  131. SANCHEZ-GUILLEN L, Blanco-Antona F, Millan-Scheiding M
    An Unusual Case of Intestinal Obstruction in Ulcerative Colitis.
    Gastroenterology. 2016 Oct 31. pii: S0016-5085(16)34813.
    PubMed     Text format    


  132. SMITH PD, Elson CO
    Elucidating the Role of the IL-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 27. pii: S0016-5085(16)35279.
    PubMed     Text format    


  133. KAPLAN GG, Ng SC
    Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.
    Gastroenterology. 2016 Oct 25. pii: S0016-5085(16)35267.
    PubMed     Text format     Abstract available


    September 2016
  134. BAMIAS G, Rivera-Nieves J
    Targeting S1P Receptors, A New Mechanism of Action for Inflammatory Bowel Disease Therapy.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35120.
    PubMed     Text format    


  135. KHANNA R, Jairath V
    Treatment Targets in Ulcerative Colitis.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35123.
    PubMed     Text format    


  136. BRANT SR, Okou DT, Simpson CL, Cutler DJ, et al
    Genome-wide Association Study Identifies African-Specific Susceptibility Loci in African Americans with Inflammatory Bowel Disease.
    Gastroenterology. 2016 Sep 28. pii: S0016-5085(16)35127.
    PubMed     Text format     Abstract available


  137. PIPER MS, Waljee A, Stidham R
    Operate or Medicate: Understanding Surgical Risks in the Elderly with Inflammatory Bowel Disease.
    Gastroenterology. 2016 Sep 28. pii: S0016-5085(16)35122.
    PubMed     Text format    


    May 2016
  138. SCHREIBER S, Vermeire S
    How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases.
    Gastroenterology. 2016;150:1061-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: